89bio, Inc

-$0.18 (-1.03%) As of 4:14 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell 89bio, Inc and other ETFs, options, and stocks.

About ETNB

89bio, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases.

CEO
Rohan Palekar
Employees
27
Headquarters
San Francisco, California
Founded
2018

ETNB Key Statistics

Market Cap
347.91M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
62.72K
High Today
$17.59
Low Today
$17.29
Open Price
$17.47
Volume
4.11K
52 Week High
$28.28
52 Week Low
$14.70

ETNB Earnings

-$1.03
-$0.69
-$0.34
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure